• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchLongboard Pharmaceuticals
    Picture of Longboard Pharmaceuticals logo

    LBPH — Longboard Pharmaceuticals News Story

    $59.980.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapMomentum Trap
    • Market Cap
      $2.34bn
    • Enterprise Value
      $2.05bn
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • LBPH Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    LBPH Dividends
    All News

    NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM

    Picture of Longboard Pharmaceuticals logoLongboard Pharmaceuticals
    13/07/2021 14:32
    NASDAQ TRADE HALT  LBPH.O  VOLATILITY TRADING PAUSE AT 09:32 AM
    

    Recent news on Longboard Pharmaceuticals

    See all news
    • Brief: Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin In Developmental And Epileptic Encephalopathies (DEEs)

      12/11/2024 13:32
    • Longboard Pharmaceuticals Inc expected to post a loss of 62 cents a share - Earnings Preview

      08/11/2024 15:53
    • Brief: Longboard Pharmaceuticals Under Agreement H Lundbeck Required To Pay Co Reverse Termination Fee Of $158.9 Mln In Cash

      15/10/2024 12:00
    • U.S. RESEARCH ROUNDUP- Cadence Design Systems, Equity Bancshares, S&P Global

      15/10/2024 08:19
    • Deals of the day-Mergers and acquisitions

      14/10/2024 21:13

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.